The reproductive conditions and lipid profile in females with epilepsy

Acta Neurologica Scandinavica

Volumn 115, Issue 1, 2007, Pages 12-22

  Hamed, S A ^a,b   Hamed, E A ^a   Shokry, M ^a   Omar, H ^a   Abdellah, M M ^a  

^a Assiut University Faculty of Medicine   (Egypt)

^b Saudi German Hospital   (Saudi Arabia)

Author keywords

Antiepileptic drugs; Epilepsy; Lipid profile; Reproductive function; Women

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PROLACTIN; TESTOSTERONE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; ECHOGRAPHY; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HORMONE DETERMINATION; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARY POLYCYSTIC DISEASE; PREVALENCE; REPRODUCTION; SCHOOL CHILD;

ADULT; AMENORRHEA; ANTICONVULSANTS; CASE-CONTROL STUDIES; EGYPT; EPILEPSY; FEMALE; GONADOTROPINS, PITUITARY; HUMANS; LIPIDS; POLYCYSTIC OVARY SYNDROME; PREVALENCE; TESTOSTERONE;

EID: 33845480996     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00740.x     Document Type: Article

References (52)

1. SCHEUER ML, PEDLEY TA. The evaluation and treatment of seizures. N Engl J Med 1990;323:1468-74.
2. FRIEDMAN MN, HERZOG AG. Epilepsy and disorders of reproduction. In: Ettinger AB, Devinsky O, eds. Managing epilepsy and co-existing disorders. Boston: Butterworth/Heinemann, 2002;305-15.
3. STOEL-WAGNER B, BAUER J, FLUGEL D, BRENNEMANN W, KLINGMULLER D, ELGER CE. Serum sex hormones are altered in patients with chronic temporal lobe epilepsy receiving anticonvulsant medication. Epilepsia 1998;39:1164-73.
4. BAIRED AD, WILSON SJ, BALDIN PF, SALING MM, REUTENS DC. Sexual outcome after epilepsy surgery. Epilepsy Behav 2003;4:268-78.
5. SCHACTER SC. Neuroendocrine aspects of epilepsy. Neurol Clin 1994;12:31-9.
6. BILO L, MEO R, NAPPI C et al. . Reproductive endocrine disorders in women with primary generalized epilepsy. Epilepsia 1988;29:612-9.
7. HAMED S, MOHAMED K, EL-TAHER A, HAMED E, OMAR H. The sexual and reproductive health in men with generalized epilepsy: a multidisciplinary evaluation. Int J Impot Res 2006;18:287-92.
8. MORRELL MI. Epilepsy in women. Am Fam Physician 2002;66:1489-95.
9. MURIALDO G, GALIMBERTI CA, MAGRI F et al. Menstrual cycle and ovary alterations in women with epilepsy on antiepileptic therapy. J Endocrinol Invest 1997;20:519-26.
10. ISOJARVI JI, LAATIKAINEN TJ, PAKARINEN AJ, JUNTUNEN KT, MYLLYLA VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993;329:1383-8.
11. STEPHEN LJ, KWAN P, SHAPIRO D, DOMINICZAK M, BRODIE MJ. Hormone profiles of young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia 2001;42:1002-6.
12. ISOJARVI JI, LOFGREN E, JUNTUNEN KS et al. Effect of epilepsy and antiepileptic drugs on male reproductive health. Neurology 2004;62:247-53.
13. BAUER J, ISOJARVI JIT, HERZOG AG et al. Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 2002;73:121-5.
14. MORRELL MJ, FLYNN KL, SEALE CG et al. Reproductive dysfunction in women with epilepsy: antiepileptic drug effects on sex-steroid hormones. CNS Spectr 2001;6:771-86.
15. COMMISSION ON CLASSIfICATION AND TERMINOLOGY OF THE INTERNATIONAL LEAGUE AGAINST EPILEPSY. Proposal for revised classification of epilepsies and patients with epilepsy syndromes. Epilepsia 1989;30:3890-9.
16. HAMED SA, HAMED EA, KANDIL MR, EL-SHEREEF HK, ABDELLAH MM, OMAR H. Serum thyroid hormone balance and lipid profile in patients with epilepsy. Epilepsy Res 2005;66:173-83.
17. NIEWOEHNER CB. Endocrine pathophysiology. Madison: Fence Ceek Publ., 1998.
18. KIDDY DS, SHARP PS, WHITE DM et al. differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome and analysis of 263 consecutive causes. Clin Endocrinol (Oxf) 1990;32:213-20.
19. BALEN AH, CONWAY GS, KALTSAS G et al. Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Hum Reprod 1995;10:2107-11.
20. PRITCHARD PB. Hyposexuality: a complication of complex partial epilepsy. Trans Am Neurol Assoc 1980;10:193-5.
21. GOMA A, ABDEL-REGAL S, ABDELLAH M, HAMED S. Monitoring antiepileptic drug therapy In Upper Egypt: a retrospective 6-years experience in Carbamazepine. J Egypt Soc Pharmacol Exp Ther 2004;25:319-35.
22. FEINSTEIN AR. Principles of medical statistics. Boca Raton, FL: Chapman and Hall/CRC, 2002.
23. HAUSER WA, ANNEGERS JF, KURLAND LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-68.
24. HERZOG AG, SEIBEL MM, SCHOMER DL, VAITUKAITIS JL, GESCHWIND N. Reproduction endocrine disorders in men with partial seizures of temporal lobe origin. Arch Neurol 1986;43:347-50.
25. CUMMINGS LN, GIUDICE L, MORRELL MMJ. Ovulatory function in epilepsy. Epilepsia 1995;36:355-9.
26. KLEIN P, SERJE A, PEZZULLO JC. Premature ovarian failure in women with epilepsy. Epilepsia 2001;42:1582-9.
27. HARDEN CL, KOPPEL BS, HERZOG AG, NIKOLOV BV, HAUSER WA. Seizure frequency is associated with age at menopause in women with epilepsy. Neurology 2003;61:451-5.
28. DANA-HAERI J, OXLEY J, RICHINS A. Reduction of free testosterone by antiepileptic drugs. Br Med J (Clin Res Ed) 1982;284:85-6.
29. BILO L, MEO R, VALENTINO R, BUSCAINO GA, STRIANO S, NAPPI C. Abnormal pattern of luteinizing hormone pulsatility in women with epilepsy. Fertil Steril 1991;55:705-11.
30. KALRA SP. Mandatory neuropeptide-steroid signaling in the preovulatory leutinizing hormone-releasing hormone discharge. Endocr Rev 1993;14:507-38.
31. MAHESH VB, BRANN DW. Regulation of the preovulatory gonadotropin surge by endogenous steroids. Steroids 1998;63:616-29.
32. BAUER J, STEFAN H, SCHRELL U et al. Serum prolactin concentrations and epilepsy: a study comparing patients in presurgical evaluation with healthy persons and circadian with seizure related variations. Eur Arch Psychiatry Clin Neurosci 1992;241:365-71.
33. MACPHEE GJ, LARKIN JG, BUTLER E, BEASTALL GH, BRODIE MJ. Circulating hormones and pituitary responsiveness in young epileptic men receiving long-term antiepileptic medication. Epilepsia 1988;29:468-75.
34. ISOJARVI JI, LAATIKAINEN TJ, PAKARINEN AJ, JUNTUNEN KT, MYLLYLA VV. Menstrual disorders in women with epilepsy receiving carbamazepine. Epilepsia 1995;36:676-81.
35. JOE H, TAYLOR AE, HALL JE. Polycystic ovarian syndrome-relationship to epilepsy and antiepileptic drug therapy. J Clin Endocrinol Metab 2001;86:2946-9.
36. DRISLANE FW, COLEMAN AE, SCHOMER DL et al. Altered pulsatile secretion of luteinizing hormone in women with epilepsy. Neurology 1994;44:306-10.
37. BONUCCELLI U, MURIALDO G, MARTINO E et al. Effects of carbamazepine on prolactin secretion in normal subjects and in epileptic subjects. Clin Neuropharmacol 1985;8:165-74.
38. MORRELL MJ, ISOJARVI J, TAYLOR AE et al. Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res 2003;54:189-99.
39. LUEF G, ABRAHAM I, TRINKA E et al. Hyperandrogenism, postprandial hyperinsulinism and the risk of PCOS in a cross sectional study of women with epilepsy treated with valproate. Epilepsy Res 2002;48:91-102.
40. YEN SSC. Polycystic ovary syndrome (hyperandrogenic chronic anovulation). In: Yen SSC, Jaffe RB, Barbieri RL, eds. Reproductive endocrinology, 4th edn. Philadelphia: WB Saunders, 1999;436-78.
41. MURIALDO G, GALIMBERTI CA, GIANELLI MV et al. Effects of valproate, phenobarbital, and carbamazepine on sex steroid setup in women with epilepsy. Clin Neuropharmacol 1998;21:52-8.
42. HERZOG AG, SEIBEL MM, SCHOMER D, VAITUKAITIS J, GESCHWIND N. Temporal lobe epilepsy: an extrahypothalamic pathogenesis for polycystic ovarian syndrome? Neurology 1984;34:1389-93.
43. RATTYA J, TURKKA J, PAKARINEN AJ et al. Reproductive effects of valproate, carbamazepine, and oxcarbazepine in men with epilepsy. Neurology 2001;56:31-6.
44. ISOJARVI JI, TURKKA J, PAKARINEN AJ, KOTILA M, RATTYA J, MYLLYLA VV. Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 2001;42:930-4.
45. HERZOG AG, FOWLER KM. Sexual hormones and epilepsy: threat and opportunities. Curr Opin Neurol 2005;18:167-72.
46. BILO L, MEO R, VALENTINO R, DI CARLO C, STRIANO S, NAPPI C. Characterization of the reproduction endocrine disorders in women with epilepsy. J Clin Endocrinol Metab 2001;86:2950-6.
47. BAUER J, JARRE A, KLINGMULLER D, ELGER CE. Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women. Epilepsy Res 2000;41:163-7
48. MICHELMORE KF, BALEN AH, DUNGER DB, VESSEY MP. Polycystic ovaries and associated biochemical features in young women. Clin Endocrinol 1999;51:779-86.
49. KNOCHENHAUER ES, KEY TJ, KAHSAR-MILLER M, WAGGONER W, BOOTS LR, AZZIZ R. Prevalence of polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998;83:3078-82.
50. HERZOG AG, SCHACHTER S. Valproate and the polycystic ovarian syndrome: final thoughts. Epilepsia 2001;42:311-5.
51. ADAMS J, POLSON DW, FRANK S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J (Clin Res Ed) 1986;293:355-9.
52. MURIALDO G, GALIMBERTI CA, FONZI S et al. Sex hormones and pituitary function in male epileptic patients with altered or normal sexuality. Epilepsia 1995;36:360-5.